$LIFE

Wang Lingke sold $776K of LIFE

Wang Lingke (President) sold 22,623 shares of Ethos Technologies Inc. (LIFE) at an average of $34.28 ($34.28–$34.80, $0.78M total) across 2 trades on 2026-08-17.

Original reporting
SEC EDGAR · Wang Lingke
Published Aug 18, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 10:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LIFE
Neutral
medium confidence
Mentioned
$LIFE
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LIFENeutralLow
01

Why it matters

This disclosure updates the record of insider ownership and may marginally affect sentiment, but it provides no new operational, financial, or regulatory information about LIFE.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a durable repricing.

03

What to watch

Absence of a 10b5-1 plan does not confirm insider knowledge; traders should look for patterns across multiple Form 4s and compare sale size to total holdings and prior activity.

Relevance 5/10Novelty 3/10Timing: filed after-hours on 2026-08-18, covering sales dated 2026-08-17

Background

The article summarizes an SEC Form 4 insider transaction for Ethos Technologies Inc. (LIFE) by President Wang Lingke.

Company-level read

Ticker impact

$LIFENeutralMedium confidence
Context

Ethos Technologies insider Wang Lingke (President) sold about $775.6K of LIFE shares via open-market transactions on 2026-08-17.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless paired with other disclosures.

Evidence & confidence

Form 4 insider sales are common and often non-informational; the article provides transaction size, price range, and post-sale holdings but no accompanying company-specific catalyst.

Market effects

No sector-level implications; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

The sale could be purely personal liquidity needs, especially since the filing does not cite any negative company development.

Key entities

  • LIFE

    Ethos Technologies Inc., subject of the Form 4 insider sale disclosure.

  • Wang Lingke

    President of Ethos Technologies Inc., reported open-market sale of shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LIFEMed

Ethos (LIFE) Grows Revenue 113% While Margins Quietly Compress

Ethos Technologies (LIFE) reported Q2 revenue growth of 113% to $189.6M, with new policies up 133%. Gross profit margin was 98%, but net income rose only 5% to $19.5M. The company authorized a $100M stock buyback. Q3 revenue guidance is $160M-$164M, and full-year guidance is $727M-$731M. Margins compressed, with GAAP net loss of $146.9M for H1 2026 due to stock-based compensation.

$LIFEMedAI 9/10

Ethos (LIFE) Q2 2026 Earnings Call Transcript

Ethos Technologies (LIFE) reported Q2 2026 revenue of $189.6 million, up 113% Y/Y, with direct revenue $116.5 million (+131%) and third-party revenue $73.1 million (+90%). Adjusted EBITDA was $35.2 million (19% margin). Net income was $19.5 million. Full-year 2026 guidance: revenue $727-$731 million and adjusted EBITDA $119-$123 million. Up to $100 million Class A repurchase authorized.

$LIFEMed

Top SMid Cap Pick: Ethos Technologies Leads Citi’s Rankings

Citi analyst Ronald Josey named Ethos Technologies (LIFE) his top SMID-cap pick after the company’s Q2 results. Activated policies growth accelerated to 133% YoY, with 107,800 net activated policies. Revenue rose to $189.6M (+113% YoY). Ethos raised 2026 revenue guidance to $727M-$731M and adjusted EBITDA to $119M-$123M. Citi lifted its price target to $33 and kept Buy/High Risk.

$LIFEHigh

Ethos Technologies Inc. (LIFE): Results of Operations and Financial Condition

Ethos Technologies Inc. (LIFE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ethos Reports Second Quarter Fiscal Year 2026 Financial Results • Q2 Revenue grew 113% year-over-year to $190 million • Q2 Direct Channel Revenue grew 131% year-over-year to $116 million • Q2 Third-Party Revenue grew 90% year-over-year to $73 million • Board of Direc